Last update 08 May 2025

Lead Chemical Co., Ltd.

Private Company|1987|Tokyo-to, Japan|
www.leadchem.co.jp

Overview

Tags

Nervous System Diseases
Immune System Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Infectious Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
COXs(Cyclooxygenases)1

Related

2
Drugs associated with Lead Chemical Co., Ltd.
Loxoprofen Sodium Hydrate
Target
COXs
Mechanism
COX inhibitors
Active Org.
Overseas Pharmaceuticals Ltd.Overseas Pharmaceuticals Ltd. [+7]
Originator Org.
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.
Active Indication
Pain, Postoperative [+14]
Inactive Indication
Myalgia [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date01 Mar 1986
LCY-018
Target
AT1R
Mechanism
AT1R antagonists
Active Org.-
Originator Org.
Lead Chemical Co., Ltd.
Active Indication-
Inactive Indication
Hypertension
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
5
Clinical Trials associated with Lead Chemical Co., Ltd.
NCT02602353
/ CompletedPhase 2
A Phase 2, Randomized, Double-Blind, Parallel-Group and Placebo-Controlled Pilot Study to Assess the Safety and Efficacy of a New Pain Patch Versus Placebo and No Treatment for the Treatment of Delayed Onset Muscle Soreness (DOMS)
ISRCTN10182003
/ CompletedNot Applicable
A randomized, controlled, double blind, double dummy clinical trial to evaluate the safety and efficacy of Loxoprofen Sodium Cataplasm ointment (Loxonin®PAP100mg) against swelling and pain caused by trauma
ISRCTN40097939
/ CompletedPhase 2
A randomized, controlled, double blind, double dummy clinical trial to evaluate the safety and efficacy of Loxoprofen Sodium Cataplasm Ointment (Loxonin®PAP100mg) against knee osteoarthritis
100 Clinical Results associated with Lead Chemical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Lead Chemical Co., Ltd.
Login to view more data
11
Literatures (Medical) associated with Lead Chemical Co., Ltd.
01 Jan 2019Proceedings for Annual Meeting of The Japanese Pharmacological Society
Decreased hippocampal GLP-1 and the shift in the circadian rhythms are induced by long-term exposure of isoflurane with surgery in mice
01 Jan 2019Proceedings for Annual Meeting of The Japanese Pharmacological Society
Isoflurane-induced postoperative cognitive impairment and enhanced abnormal social interaction are associated with decrease in hippocampal dopamine D<sub>2</sub> receptor in mice
01 Jan 2008Chemical and Pharmaceutical BulletinQ4 · MEDICINE
New Chromane Derivatives Isolated from the Brown Alga, Sargassum micracanthum
Q4 · MEDICINE
100 Deals associated with Lead Chemical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Lead Chemical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Loxoprofen Sodium Hydrate
 ( COXs )		Pain
More
Approved
LCY-018
 ( AT1R )		Hypertension
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free